Author/Authors :
Tsuchida، نويسنده , , Keiichi and Ong، نويسنده , , Andrew T.L. and Aoki، نويسنده , , Jiro and van Mieghem، نويسنده , , Carlos A.G. and Rodriguez-Granillo، نويسنده , , Gastَn A. and Valgimigli، نويسنده , , Marco and Sianos، نويسنده , , Georgios and Regar، نويسنده , , Evelyn and McFadden، نويسنده , , Eugène P. and van Der Giessen، نويسنده , , Willem J. and de Feyter، نويسنده , , Pim J. ، نويسنده ,
Abstract :
The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.
